A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2001
11/28/2001	EP1157001A1 Oxamic acids and derivatives as thyroid receptor ligands
11/28/2001	EP1157000A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
11/28/2001	EP1156999A1 Method for the preparation of a chiral-beta-amino ester
11/28/2001	EP1023085A4 Human embryonic germ cell line and methods of use
11/28/2001	EP0983068B1 THE USE OF 1,2,4-TRIAZOLO 1,5-c]PYRIMIDINE HETEROCYCLIC ANALOGUES FOR THE PREPARATION OF MEDICAMENTS USEFUL FOR THE TREATMENT OF CEREBROVASCULAR DISTURBANCES
11/28/2001	EP0906268B1 Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors
11/28/2001	EP0850234B1 Novel heterocyclic compounds for the treatment of pain and use thereof
11/28/2001	EP0845993B1 Use of plasminogene activators to stimulate local bone growth
11/28/2001	EP0845032B1 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
11/28/2001	EP0830344B1 2-substituted benzimidazole derivatives as smooth muscle cell proliferation inhibitors
11/28/2001	EP0817622B1 Medicament with angiotensin converting enzyme (ace) inhibitors suitable for transdermal application
11/28/2001	EP0804469B1 T-cell affecting peptides
11/28/2001	EP0783503B1 2,7-substituted octahydro-1h-pyrido[ 1,2-a]pyrazine derivatives
11/28/2001	EP0770068B1 Conformationally rigid bicyclic and adamantane derivatives useful as alpha 2-adrenergic blocking agents
11/28/2001	EP0673368B1 Novel nicotinic acid esters
11/28/2001	EP0660716B1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
11/28/2001	CN1324403A PRV-1 gene and the use thereof
11/28/2001	CN1324367A Cyclic prosaposin-derived peptides and uses thereof
11/28/2001	CN1324350A Benzoylpyridazines
11/28/2001	CN1324347A Arylpiperzines as metalloproteinase inhibiting agents (MMP) and their use
11/28/2001	CN1324251A Method of stimulating prosaposin receptor activity
11/28/2001	CN1324242A Novel NEUROPILIN/growth factor binding and use thereof
11/28/2001	CN1324240A Treatment of disorders of the outer retina
11/28/2001	CN1324236A Delta 9 tetrahydrocannabinol (delta 9 THC) solution metered dose inhalers and methods of use
11/28/2001	CN1324233A Controlled-release pharmaceutical formulations contg. a CGMP PDE-5 inhibitor
11/28/2001	CN1323800A Pseudo gensenoside-Pgq and its semi-synthesis and medicinal use
11/28/2001	CN1323797A Chinese chestnut flower flavone compound and its extraction process
11/28/2001	CN1323793A Schizonepeta lactone and its extraction process and use
11/28/2001	CN1323631A Paralysis treating medicine bolus
11/28/2001	CN1323624A Xueduqing capsule, oral liquid and mask for eliminating blood toxin
11/28/2001	CN1323616A Medicine for treating burns, scalds and body odour
11/28/2001	CN1323606A Wound curing and swelling-eliminating tranditional Chinese medicine ointment and its pharmaceutical application
11/28/2001	CN1323598A Antifatigue capsule
11/28/2001	CN1075387C Antitumor agent potentiator comprising IL-6 antagonist
11/28/2001	CN1075379C Composite tea of wild nine-leaf gunostema pentaphyllum
11/28/2001	CN1075375C Compounds with progesterone-antagonistic and anti-oestrogen properties intended from combined use in female contraception
11/27/2001	US6323326 Method of solubilizing, purifying, and refolding protein
11/27/2001	US6323241 Prostaglandin compositions and methods of treatment for male erectile dysfunction
11/27/2001	US6323240 4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
11/27/2001	US6323234 Methods to treat gastrointestinal lesions and to reduce drug-induced gastrointestinal or renal toxicity
11/27/2001	US6323232 Combination therapy for osteoporosis
11/27/2001	US6323230 Epicuaneous route in the case of dermatological illnesses like psoriasis, atopic dermatitis and other similar affections, or when administered by oral or rectal route in the case of diseases of the epithelia of the lower intestines
11/27/2001	US6323229 Compounds are useful psychotherapeutics and are potent agonists and/or antagonists of the serotonin 1a (5-ht 1a) and/or serotonin 1d (5-ht 1d) for treatment of hypertension, depression, generalized anxiety disorder
11/27/2001	US6323228 3-substituted indole angiogenesis inhibitors
11/27/2001	US6323225 Pharmaceutical composition
11/27/2001	US6323223 Ccr-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.
11/27/2001	US6323222 1-aza-2-alkyl-6-aryl-cycloalkane compounds
11/27/2001	US6323218 Treatment of alzheimer*s disease with metal chelates for amyloidosis
11/27/2001	US6323217 Cardiovascular disorders
11/27/2001	US6323216 Selective antagonists of the 5-ht.sub.3 serotonin-like receptor and can therefore be used, as anti-emetics as well as in various pathological conditions of the central nervous system, and as antitussives.
11/27/2001	US6323212 Method for reducing pain, which comprises administering an effective analgesic amount of the morphinan derivative
11/27/2001	US6323208 Compounds to treat neurodegenerative, psychotropic drug and alcohol induced central and induced central and peripheral nervous system disorders.
11/27/2001	US6323206 Antiinflammatory agents and viricides for aids with cytokinesand chemokines
11/27/2001	US6323201 Compounds for inhibition of ceramide-mediated signal transduction
11/27/2001	US6323197 Non-competitive inhibiting of the ampa receptors, these compounds can be used as medicaments for treatment of the central nervous system
11/27/2001	US6323191 Generation of chloride secretion from epithelial cells
11/27/2001	US6323184 Arteriovenous and venous graft treatments: methods and compositions
11/27/2001	US6323029 Therapeutic, diagnostic, and research applications for the modulation of glycogen synthase kinase 3 beta expression
11/27/2001	US6323028 Isolated peptides which comply with HLA-CW16 molecules and uses
11/27/2001	US6323003 Compositions and methods for activating genes of interest
11/27/2001	US6322806 Over-coated chewing gum formulations including tableted center
11/27/2001	US6322790 Treatment of primary and metastatic noeplastic diseases and infectious diseases; administering antigen presenting cells sensitized with complexes of hsps noncovalently bound to an antigenic molecule
11/27/2001	US6322784 Glucocorticoid, a compound which stimulates camp production and compound which upregulates peroxisome proliferator activated receptor .gamma. expression
11/27/2001	CA2025294C Bile acid derivatives, processes for their preparation, and use as pharmaceuticals
11/25/2001	CA2309417A1 Apoptotic entities for use in treatment of endothelium dysfunction disorders
11/22/2001	WO2001088199A2 Identification and modulationof of a t helper-1 and t helper-2 cells
11/22/2001	WO2001088148A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/22/2001	WO2001088136A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/22/2001	WO2001088134A2 Novel human lipocalin homologs and polynucleotides encoding the same
11/22/2001	WO2001088131A1 Regulation of mt1-mmp activity
11/22/2001	WO2001088129A1 Anti-angiogenic polypeptides
11/22/2001	WO2001088125A1 MUTATION IN THE β2 NICOTINIC ACETYLCHOLINE RECEPTOR SUBUNIT ASSOCIATED WITH NOCTURNAL FRONTAL LOBE EPILEPSY
11/22/2001	WO2001088116A2 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods
11/22/2001	WO2001088108A1 Neuronal serine-threonine protein kinase
11/22/2001	WO2001088103A2 Compositions and methods for tissue dedifferentiation and regeneration
11/22/2001	WO2001088096A2 Ovine tissue for xenotransplantation
11/22/2001	WO2001087981A2 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
11/22/2001	WO2001087980A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/22/2001	WO2001087937A2 G-protein coupled receptors
11/22/2001	WO2001087935A2 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
11/22/2001	WO2001087928A1 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity
11/22/2001	WO2001087923A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
11/22/2001	WO2001087913A2 Method for treating retinal degeneration with purinergic receptor agonists
11/22/2001	WO2001087892A1 Crf receptor antagonists
11/22/2001	WO2001087890A1 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
11/22/2001	WO2001087889A1 Crf receptor antagonists and methods relating thereto
11/22/2001	WO2001087887A2 Neuroprotective and anti-proliferative compounds
11/22/2001	WO2001087886A1 Crf receptor antagonists and methods relating thereto
11/22/2001	WO2001087882A2 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
11/22/2001	WO2001087881A1 Piperidyindoles as serotonin receptor ligands
11/22/2001	WO2001087880A1 1-(benzothiazol-2-yl)pyrazole derivatives and cox-2 inhibitors containing the same
11/22/2001	WO2001087879A1 New thiochromane derivatives and their use as thrombin inhibitors
11/22/2001	WO2001087877A1 Novel thiophenamide compounds
11/22/2001	WO2001087870A1 Hydroxamic acid derivatives
11/22/2001	WO2001087866A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	WO2001087854A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
11/22/2001	WO2001087849A2 Modulators of tnf- alpha signaling
11/22/2001	WO2001087846A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
11/22/2001	WO2001087845A2 N-containing heterocyclic compounds and their use as 5-ht antagonists
11/22/2001	WO2001087844A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity

1 ... 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 ... 1564